Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Comparison of hepatitis C virus treatment between incarcerated and community patients.

Rice JP, Burnett D, Tsotsis H, Lindstrom MJ, Cornett DD, Voermans P, Sawyer J, Striker R, Lucey MR.

Hepatology. 2012 Oct;56(4):1252-60. doi: 10.1002/hep.25770.

PMID:
22505121
[PubMed - indexed for MEDLINE]
2.

Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.

Hartwell D, Jones J, Baxter L, Shepherd J.

Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170. Review.

PMID:
21473834
[PubMed - indexed for MEDLINE]
Free Article
3.

Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.

Innes HA, Hutchinson SJ, Allen S, Bhattacharyya D, Bramley P, Carman B, Delahooke TE, Dillon JF, Goldberg DJ, Kennedy N, Mills PR, Morris J, Morris J, Robertson C, Stanley AJ, Hayes P; Hepatitis C Clinical Database Monitoring Committee.

Eur J Gastroenterol Hepatol. 2012 Jun;24(6):646-55. doi: 10.1097/MEG.0b013e32835201a4. Review.

PMID:
22433796
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk